Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It is also available as a dietary supplement
Williams, a 23-time Grand Slam champion, told Elle magazine that after having her second child in 2023, she lost weight within two weeks, but no matter what she did after that, she couldnt lose more
Researchers designing comparative protocols should treat the two compounds as related but mechanistically distinct tools rather than a single compound at different potencies
Financial Dominance & Operating Leverage Q3 2025 Financial Highlights Revenue: $17.6B (+54% YoY) Non-GAAP EPS: $7.02 (+495% YoY) Gross Margin: 83.6% (+1.4 pts) Operating Cash: Strong (Record levels) Full-Year 2025 Guidance (Raised) Revenue: $63.0-63.5B (up from $60-62B) Non-GAAP EPS: $23.00-23.70 (up from $21.75-23.00) Profitability Metrics Return on Equity (ROE): ~74-88% (exceptional capital efficiency) Gross Margin: 83.6% (among highest in pharma) R&D Investment: $3.47B in Q3 (+27% YoY) fueling future growth These metrics place Lilly among the most efficient, profitable companies in the S&P 500
You accidentally added too much water
W., Leite-Moreira, A
US$ 26.49
US$ 26.56
US$ 26.18
US$ 27.21
